Related Experiment Video
Updated: Jun 25, 2026
07:54
Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
The patient presenting with isolated hyperbilirubinemia.
L Fabris1, M Cadamuro, L Okolicsanyi
1Department of Surgical and Gastroenterological Sciences, University of Padova, UOC Gastroenterologia, Ospedale Cà Foncello, Treviso, Padova, Italy.
Summary
Familial hyperbilirubinemia, often considered benign, may increase drug toxicity risk due to impaired bilirubin metabolism. Understanding bilirubin metabolism and genetic factors is key for diagnosis and management.
Area of Science:
- Biochemistry
- Genetics
- Clinical Medicine
Background:
- Hyperbilirubinemia is a common finding in clinical practice, associated with liver and hematological diseases.
- Familial hyperbilirubinemia, present in 5-10% of Western populations, is increasingly recognized for its implications beyond benignity.
- Emerging evidence links impaired bilirubin metabolism to heightened susceptibility to drug toxicity.
Purpose of the Study:
- To review bilirubin metabolism, focusing on nuclear receptor regulation and genetic factors.
- To systematically analyze various forms of isolated hyperbilirubinemia in adults and pediatrics.
- To propose a novel categorization of hyperbilirubinemia based on recent research advancements.
Main Methods:
- Review of current literature on bilirubin metabolism and its regulation.
- Systematic analysis of clinical data on isolated hyperbilirubinemia.
- Development of a diagnostic algorithm and management strategy.
Main Results:
- Detailed overview of bilirubin metabolism, highlighting molecular mechanisms.
- Classification of familial hyperbilirubinemia forms with updated insights.
- Proposed diagnostic and management pathways for hyperbilirubinemia.
Conclusions:
- Impaired bilirubin metabolism warrants attention due to potential drug toxicity risks.
- A revised understanding of bilirubin metabolism, including genetic and nuclear receptor roles, is crucial.
- A structured diagnostic and management approach can prevent unnecessary investigations.
Related Concept Videos
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...